Drugs & Targets TheraBionic P1 device receives European regulatory approval August 03, 2018Vol.44 No.31
Drugs & Targets Keytruda + pemetrexed and platinum gets EMA’s positive opinion for first-line NSCLC August 03, 2018Vol.44 No.31
Drugs & Targets Tafinlar + Mekinist gets positive CHMP opinion for adjuvant BRAF V600 mutation-positive melanoma August 03, 2018Vol.44 No.31
Drugs & Targets Lenvima + Keytruda get Breakthrough designation for endometrial carcinoma August 03, 2018Vol.44 No.31
Drugs & Targets Pfizer receives European approval for biosimilar trastuzumab August 03, 2018Vol.44 No.31
Drugs & TargetsFree FDA approves magnetic device system for sentinel biopsies in breast cancer July 27, 2018Vol.44 No.30
Drugs & TargetsFree FDA accepts Celyad IND application for CYAD-101, a non-gene edited allogeneic CAR-T candidate July 27, 2018Vol.44 No.30
Drugs & TargetsFree BMS, Tsinghua University to develop therapies for autoimmune diseases, cancer July 27, 2018Vol.44 No.30
Drugs & Targets FDA grants breakthrough designation for Tecentriq + Avastin as first-line treatment for hepatocellular carcinoma July 20, 2018Vol.44 No.29
